Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
business
business sponsored company news
articles containing video clips
colloids
dosage forms
drug delivery devices
gels
histopathology
infectious causes of cancer
male genital neoplasia
neoplastic and hyperplastic prostate disorders
physical chemistry
prostate cancer
rtt
What
absorbable
announced
augmenix
company
develops
hydrogel
7
×
hydrogels
manufactures
medical
organs
press
7
×
protect
radiotherapy
7
×
release
risk
sells
separate
spaceoar
7
×
technology
announces
proprietary
cancer
prostate
today
treated
data
medicare
new
patient
patients
radiation
administrative
american
analysis
association
benefits
canada
code
company's
contractor
Language
Current search:
press
×
hydrogel
×
spaceoar
×
radiotherapy
×
@venturebeat.com
6 years ago
Augmenix® Announces Medicare Reimbursement Rates for the new CPT Code 55874, which will be used to bill SpaceOAR® Hydrogel, Effective January 2018
@venturebeat.com
7 years ago
Augmenix, Inc. Announces Medicare Administrative Contractor Palmetto Coverage for SpaceOAR® Hydrogel
@venturebeat.com
7 years ago
Augmenix Announces First Prostate Cancer Patients Treated with SpaceOAR® Hydrogel in Israel
@venturebeat.com
7 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in New Zealand
@venturebeat.com
7 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in Canada
@venturebeat.com
7 years ago
Phase 3 Trial Data Show Use of SpaceOAR® Hydrogel Helps Maintain Erectile Function Following Prostate Cancer Radiation Treatment
@venturebeat.com
7 years ago
Augmenix Announces Positive Three-Year Long-Term Data Highlighting Benefits of SpaceOAR® Hydrogel Spacer for Patients with Prostate Cancer